Office Contact Info.
Phone: (631) 344-3604
Fax: (631) 344-2358
Mail address: Bldg. 490
|
![](Srivastava-sm.jpg) |
Suresh Srivastava
Scientist
Telephone: (631) 344-4459
e-mail: suresh@bnl.gov
|
Research Interests
- Novel radionuclide and radiopharmaceuticals for oncologic imaging and
therapy
- Molecular contructors for gene/radioisotopic therapy
- Suresh Srivastava’s interests are the development, testing, and
clinical trials of:
1) Sn-117m chelates for treatment of bone pain,
primary/ metastatic bone cancer, and rheumatoid arthritis; and 2) Anti-angiogenic
peptides, metalloproteinase inhibitors, and STTR-binding peptides, labeled
with no-carrier-added Sc-47, Sn-117m, Hg-195m, and other radioisotopes,
for tumor therapy. In addition, he is interested in the development of
radiolabeled recombinant fusion proteins, scFv antibodies, and viral
vectors as vehicles for therapy of cancer.
|